Full-Time

Associate Vice President Radiation Oncology

Posted on 11/7/2025

Deadline 11/4/27
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

1,001-5,000 employees

Nonprofit cancer treatment, research, and trials

Compensation Overview

$213.3k - $375.1k/yr

+ Relocation Assistance + Sign-On Bonus

No H1B Sponsorship

Seattle, WA, USA

In Person

Category
Business & Strategy (1)
Requirements
  • Bachelor's degree or equivalent experience in Hospital Administration, Health Care Administration, Business Administration, or a related field is required
  • 5-7 years of management experience in a leadership position within a complex healthcare environment, balancing the missions of clinical care, teaching and research
  • Direct experience in radiation oncology
  • In-depth knowledge and experience in radiation oncology-specific operations
  • In-depth knowledge of finance and revenue cycle and market forces
  • Demonstrated ability to lead in complex, matrixed organizational structures with multiple stakeholders
  • Strong financial acumen including P&L management, capital planning, and business case development
Responsibilities
  • Provides administrative leadership of the Radiation Oncology enterprise including Fred Hutch's Radiation Oncology Program as well as the Integrated Radiation Oncology Program with UW Medicine
  • Oversight of clinical, financial, staffing, equipment and facilities for Radiation Oncology in Fred Hutch owned locations and integration and alignment for UW Medical Center-based operations
  • Ensures operational excellence for advanced treatment modalities including proton therapy and neutron therapy, optimizing equipment utilization, patient scheduling, and clinical workflows specific to these specialized services
  • Oversees equipment lifecycle management, capital planning, and regulatory compliance for radiation therapy systems
  • Leads operational implementation for Radiation Oncology care access and experience, patient flow and upstream/downstream care management and strategic partnerships and ensures development and consistent delivery of patient care and an operating system across locations
  • Partners with the scientific division leadership and Department Chair/SVP to the academic activities of the scientific division, including faculty recruitment, seminar series, pilot grant program
  • The AVP will be responsible for developing and submitting the annual budget for the Division in partnership with the SVP and Chair
  • Accountable for continuous quality improvement and ensuring greater standardization of care processes in partnership with Radiation Oncology physician leadership and improving accessibility/ patient care experience across Radiation Oncology at all sites
  • Works effectively with system shared clinical services and the Department of Radiation Oncology to assure effective deployment of services in each location
  • Responsible for P&L for Fred Hutch owned Radiation Oncology sites. Monitors and improves financial and service results. Effectively connects operations to funds flow models and revenue cycle processes to improve affordability and financial results. Advises the Chair regarding capital budget and budget strategies for sites and prioritizes capital expenditures within budget constraints
  • Develops and uses standard metrics and dashboards and makes those visible across the enterprise to create common understanding of current financial and operational state. Creates and implements action plans to achieve desired outcomes for financial and operational improvement
  • Works collaboratively with SVP/Chair to integrate research activities into clinical operations, ensuring appropriate resource allocation and space planning for research programs
  • Supports faculty recruitment efforts aligned with research and clinical growth strategies
  • Partners with the SVP/Chair, scientific leadership, and VP of Clinical Research to enhance patient access to clinical trials
  • Partners with the central clinical trials office, Clinical Research Support (CRS), to ensure operational support for the clinical research portfolio including multi-institutional research collaborations and cooperative group trials
  • Supports the faculty-led development of the Radiation Oncology research portfolio and department; and seeks to expand patient access to clinical trials through operational excellence and strategic planning
  • Responsible for the administrative activities of the Radiation Oncology Division, including faculty recruitment, seminar series, and faculty affairs; responsible for developing administrative needs as the scientific division grows
  • Serves key leadership role in ongoing Radiation Oncology enterprise strategic planning and leads eventual plan implementation
  • Contributes to development of strategic direction and vision for Radiation Oncology delivery with enterprise-wide strategic direction/vision; serves as communication link between Department and Cancer Center senior management and clinical program leadership
  • Develops a deep understanding of market dynamics and enterprise assets and constraints, partnering with Fred Hutch and UW Medicine stakeholders to develop and execute a plan for growth including potential additional sites, recruitment, partnerships and additive technology and modalities
  • Develops strategic plans to optimize utilization of advanced treatment technologies (proton therapy, neutron therapy, theranostics) and evaluates emerging technologies and treatment modalities for potential clinical adoption
  • Leads business planning for new service lines and expansion opportunities
  • Collaborates with the Chair Radiation Oncology and Vice Chair of Radiation Oncology for Clinical Affairs across the integrated Radiation Oncology program to architect and implement a governance and management structure for all sites and activities that fosters greater clarity in decision making, reduced variability in care processes and excellence in patient experience
  • Supports the development and fosters effective collaboration between clinical departments, faculty, locations, internal and external organizational partners and other affiliated groups to ensure an integrated approach to providing services and that the full resources of the newly aligned integrated program are brought to bear
  • Interfaces with colleagues across Fred Hutch and UW Medicine to ensure alignment and engagement for systemwide initiatives and to ensure appropriate resource allocation to meet goals, priorities, and deadlines
  • Facilitates collaborative problem solving among disciplines, departments and entities
  • Implements strategies that provide optimal support and development of high functioning teams contributing to successful recruitment and retention of talent
  • Role models and fosters an environment of professionalism and employee engagement across the Radiation Oncology enterprise, creating an effective culture which ensures an engaged workforce; creates and maintains a culture where employee input is valued and recognized
  • Other duties and responsibilities as assigned
Desired Qualifications
  • A graduate degree in Health Care Administration, Business Administration, or a related field is preferred
  • Experience with proton and neutron therapy; Experience in an organization that includes multiple sites and partner organizations is preferred
  • Familiarity with NIH/NCI grant mechanisms and research compliance requirements
  • Management experience in a leadership position within a complex academic environment
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

View

Fred Hutchinson Cancer Center is a nonprofit cancer treatment and research institute serving the Pacific Northwest and beyond. It provides a full range of cancer care, including treatments that may not be available elsewhere, and offers patients the chance to participate in clinical trials. The center accomplishes its work through a combination of patient care, research grants, and fundraising, and collaborates with UW Medicine and other regional providers to extend its reach. Internationally, it operates facilities in Uganda and South Africa to advance research and collaboration. The organization’s revenue comes from patient services, grants, and fundraising events. Its central goal is to eliminate cancer and related diseases by improving treatments and ultimately finding a cure.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$300K

Headquarters

Seattle, Washington

Founded

1975

Simplify Jobs

Simplify's Take

What believers are saying

  • Ai2, Google Cloud add $20M to Cancer AI Alliance's $40M funding.
  • Global sites in Uganda, South Africa enable diverse AI training data.
  • NCI-designated center since 1973 drives research grants, fundraising.

What critics are saying

  • AWS, Microsoft, NVIDIA cut commitments, halting 2025 AI results.
  • Dana-Farber, MSK erode Fred Hutch's precision oncology referrals.
  • NIH grants lapse, Obliteride donors drop in recession by 2027.

What makes Fred Hutchinson Cancer Center unique

  • Fred Hutch leads Cancer AI Alliance coordinating Dana-Farber, MSK, Johns Hopkins.
  • Offers 750+ active clinical trials, most in Pacific Northwest.
  • Pioneers precision oncology via Stuart and Molly Sloan Institute.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Paid Parental Leave

Sabbatical Leave

Tuition Reimbursement

Company News

GeekWire
Apr 17th, 2025
Tech Moves: Smartsheet Names Chief Product Officer; Meta Vet Joins Tech Alliance; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Arora. (Smartsheet Photo)— Pratima Arora has been named chief product officer at Smartsheet, a new senior executive role at the Bellevue, Wash.-based enterprise software giant.A longtime product and technology leader, Arora will be responsible for Smartsheet’s product management, product marketing, user experience, pricing and packaging, and digital and product partnerships.She previously held senior leadership roles at Atlassian and Salesforce, and was most recently the chief product and technology officer at Chainalysis.“After a fantastic 4-month break to recharge, spend quality time with family, and dive deep into the world of GenAI, I’m energized and ready for what’s next,” Arora said on LinkedIn. “There’s no better place than Smartsheet to begin this new chapter. With a strong foundation, a passionate customer base, and a unique opportunity to reimagine collaborative work through AI, the road ahead is full of possibility.”Smartsheet also announced that Nick Dunn, an eight-year veteran of the company, is now general counsel, responsible for leading the company’s legal, privacy, and risk functions, including corporate governance initiatives.Launched in 2005, Smartsheet makes cloud-based enterprise work management technologies for managing and tracking projects, collaborating, storing data, and automating and assigning tasks, among other capabilities. It serves 85% of the Fortune 500 as customers

PR Newswire
Apr 4th, 2025
Google Cloud And Ai2 Commit $20M To Advance Ai-Powered Research For The Cancer Ai Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer modelsSEATTLE and SUNNYVALE, Calif., April 4, 2025 /PRNewswire/ -- Today, Google Cloud and Ai2 announced they have partnered with the Cancer AI Alliance (CAIA), a pioneering consortium uniting leading cancer research institutions and technology companies to harness artificial intelligence (AI) in the fight against cancer. Google Cloud and Ai2 are each giving $10 million to the initiative and providing access to technology solutions that will help speed scientific discovery. Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research

GeekWire
Apr 4th, 2025
Ai2 And Google Cloud Join Cancer Ai Alliance With A Total Of $20M In Commitments

Inside the Allen Institute for AI in Seattle. (GeekWire File Photo / Todd Bishop)The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10 million in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center.Google Cloud is also committing $10 million in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data. They say the goal is to create a novel AI infrastructure that supports the training and deployment of AI models across institutions while maintaining data security and privacy standards for patients.The Cancer AI Alliance was announced in October 2024 as a joint effort among four major cancer centers: Fred Hutch, Dana-Farber, Memorial Sloan Kettering, and Johns Hopkins. Backed by more than $40 million in initial support from AWS, Microsoft, NVIDIA, Deloitte, and Slalom, the project aims to use artificial intelligence to analyze large volumes of cancer data across institutions. Seattle-based Fred Hutch is serving as the lead coordinating center.Ai2 CEO Ali Farhadi in his Seattle office. (GeekWire File Photo / Todd Bishop)In a previous interview with GeekWire, Ai2 CEO Ali Farhadi said the Cancer AI Alliance represents the kind of real-world challenge that needs customized, domain-specific AI models. The Seattle-based AI institute focuses on open-source artificial intelligence technologies.Farhadi said Ai2’s role in the Cancer AI Alliance reflects Ai2’s goal to apply cutting-edge research where it can have the most tangible impact on the world.“Any step in the right direction in that space is going to be a risk worth taking, and that’s the kind of impact that we’re after,” Farhadi said, explaining Ai2’s ambitions for 2025 on the GeekWire Podcast. “If you’re actually trying to solve a real problem, there is no turnkey solution.”The Cancer AI Alliance has said it expects initial research results by the end of 2025

GeekWire
Mar 18th, 2025
Geekwire Awards: Health Innovation Of The Year Field Is Dominated By Finalists Battling Cancer

The 2025 GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with groundbreaking new technologies. The contenders range from a newly formed startup to a leading U.S. cancer institute and companies in between. Joining the cohort is a business with technology to help healthcare providers better manage appointments and access to providers.This awards category recognizes pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for improving peoples’ lives and enhancing the healthcare system.The finalists are Archon Biosciences, DexCare, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma.Last year’s winner was CalmWave, a Seattle health-tech startup that created a system for making sense of the alarms triggered by the devices that monitor hospital ICU patients.Continue reading for details on each of this year’s finalists, and vote here or below.Archon BiosciencesArchon Biosciences emerged from stealth last October with $20 million in funding. The Seattle biotech company is running with technology developed in the lab of University of Washington biochemist and Nobel Prize winner David Baker.Archon’s proprietary protein structures, known as Antibody Cages or AbCs, combine two biomedical tools — naturally occurring antibodies and custom-designed proteins — to create a single new protein structure. These protein structures, or AbCs, are optimized with the aid of generative AI to travel in the body in controllable ways and engage with target cells in a more specific manner.“What we like to say is, it’s not whether you’re given a drug, it’s how you’re given it,” said CEO and co-founder James Lazarovits

GeekWire
Mar 12th, 2025
Tech Moves: Longtime Google Leader Umesh Shankar Joins Microsoft As New Corporate Vp

Umesh Shankar. (LinkedIn Photo). After nearly 19 years at Google, Umesh Shankar has joined Microsoft AI as a corporate vice president of engineering.Shankar, based in New York City, has focused his career on privacy and security. His last role at Google was chief technologist and distinguished engineer for Google Cloud Security. Shankar will lead a new privacy and security engineering effort focused on Microsoft’s Copilot AI assistant, according to Microsoft AI CEO Mustafa Suleyman.“I believe that investing in a secure technical foundation will actually allow us to innovate with AI faster than we could in a world where giving AI more data and tools comes with unknown or unbounded risk,” he said on LinkedIn. “That’s why I’ll be focusing on building systems and platforms that have strong protections and user control built in.”Shankar is the latest Google leader to join Microsoft AI in recent months

INACTIVE